Daniel Barber, Chief Executive Officer at Aquestive Therapeutics, Inc. (AQST), bought 183,486 shares at $0.96 ($176K) on 2022-06-08, disclosed to the SEC on 2022-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 91,743 | $88K | 50.0% |
| 2 | $0.96 | 91,743 | $88K | 50.0% |
| Total | $0.96 avg | 183,486 | $176K | 100% |
| Filing → |
| AQST | SELL | 2026-07-17 | $100K | — | Filing → |
| AQST | SELL | 2026-06-16 | $104K | — | Filing → |
| AQST | SELL | 2026-05-18 | $35K | — | Filing → |